Artificial Intelligence in Pharmacovigilance
Revolutionize drug safety monitoring by promoting a cutting-edge AI technologies.
ISoP SIGs
Artificial Intelligence in Pharmacovigilance
The ISoP Special Interest Group (SIG) on Artificial Intelligence in Pharmacovigilance, led by Mohammed Fouda, Head of the Signal Detection Section at the Saudi Food and Drug Authority, aims to revolutionize drug safety monitoring by promoting cutting-edge AI technologies. Our goal is to enhance efficiency, accuracy, and predictive capabilities in adverse event reporting, thereby fostering a safer future for public health. By addressing challenges such as data quality, regulatory compliance, and ethical AI models, the SIG strives to be a global leader in transforming pharmacovigilance practices.
The SIG was officially launched during the ISoP General Assembly in October 2024 in Montreal.
Objectives
- Promote AI Integration: Encourage the adoption of AI technologies within pharmacovigilance to improve drug safety and efficacy.
- Drive Innovation: Facilitate the development and application of machine learning and natural language processing in adverse event reporting.
- Enhance Collaboration: Build a community of professionals to share knowledge, best practices, and research on AI-driven pharmacovigilance.
- Support Ethical Practices: Advocate for ethical AI frameworks that ensure compliance with regulatory standards and uphold patient safety.
- Advance Education: Organize educational programs, webinars, and workshops to empower professionals with AI knowledge and skills.
Activities and Plans
- Webinar Series : Launch a series of expert-led webinars focusing on the application of AI in pharmacovigilance. Topics will include AI ethics, regulatory compliance, and the latest advancements in technology.
- Networking Opportunities: Facilitate discussions and collaborations among global experts in pharmacovigilance and AI.
- Research and Development Initiatives: Encourage members to participate in joint research projects, contributing to the development of innovative AI solutions for pharmacovigilance.
- Resource Sharing: Provide members with access to curated resources, including case studies, white papers, and regulatory updates on AI in pharmacovigilance.
Would you like to join or learn more about this group? Contact us at administration@isoponline.org
